The board of directors of the Pharmaceuticals conglomerate, Glaxo-SmithKline, has approved the establishment of an antibiotics plant in Algeria, reported Damien Carpanini, the company’s vice-president for human resources, responsible for the Middle East and North Africa, as quoted by the Gulf News. According to Carpanini, the Algerian project will be completed within 24 months.
In the Middle East and North Africa region, Glaxo-SmithKline already has manufacturing plants in Saudi Arabia, Egypt, Morocco and Turkey. The region is expected to contribute about $595 million to the company's $22.6 billion in revenues forecast for 2001. — (Albawaba-MEBG)
© 2001 Mena Report (www.menareport.com)
© 2000 - 2019 Al Bawaba (www.albawaba.com)